The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcomes of a prospective single institution study with multiagent chemotherapy and stereotactic body radiation therapy in locally advanced or recurrent pancreatic adenocarcinoma.
 
Colin Hill
No Relationships to Disclose
 
Lauren M. Rosati
No Relationships to Disclose
 
Hao Wang
No Relationships to Disclose
 
Hua-Ling Tsai
No Relationships to Disclose
 
Shuchi Sehgal
No Relationships to Disclose
 
Vincent Bernard
No Relationships to Disclose
 
John L. Cameron
No Relationships to Disclose
 
Jin He
No Relationships to Disclose
 
Amy Hacker-Prietz
No Relationships to Disclose
 
Daniel A. Laheru
No Relationships to Disclose
 
Lei Zheng
Stock and Other Ownership Interests - Z and L International Medical
Consulting or Advisory Role - Alphamab; AstraZeneca; Biosynergies; DataRevive; Foundation Medicine; Merck; Merrimack; Mingruizhiyao; novarock
Research Funding - Amgen; Bristol-Myers Squibb; Gradalis; Halozyme; InxMed; ITeos Therapeutics; Merck; NovaRock
Patents, Royalties, Other Intellectual Property - GVAX, licensed to Aduro Biotech.
 
Richard A. Burkhart
No Relationships to Disclose
 
Ana De Jesus-Acosta
No Relationships to Disclose
 
Dung T. Le
Honoraria - Merck
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Curegenix; Medivir; Merck
Patents, Royalties, Other Intellectual Property - Inventor of technology, "Microsatellite Instability as a Pharmacogenomic Marker of Therapeutic Response to Immune Checkpoint Inhibition".
 
Matthew John Weiss
No Relationships to Disclose
 
Christopher Lee Wolfgang
No Relationships to Disclose
 
Amol Narang
Research Funding - Boston Scientific
 
Joseph M. Herman
Consulting or Advisory Role - Bristol-Myers Squibb; Sirtex Medical
Research Funding - 1440 Foundation (Inst); Augmenix (Inst); Galera Therapeutics (Inst); Stand up to Cancer (Inst)